SFEBES2019 POSTER PRESENTATIONS Thyroid (51 abstracts)
Rates of maternal complications from TRAb positive pregnancies are low, but strongly positive TRAb in later pregnancy is associated with adverse neonatal outcomes
Isabel Huang Doran 1 , James McFarlane 1 , John Clark Glasgow 1 , Eirini Bikou 2 , Emilomon Inetinbor 2 , Charleen Lia 2 , Anna Stears 1 , Diana Wood 3 , Katarzyna Gajewska-Knapik 2 , Amanda Ogilvy-Stuart 2 , Krishna Chatterjee 1 & Carla Moran 1
1Institute of Metabolic Science, University of Cambridge, Cambridge, UK; 2Rosie Hospital, Cambridge, UK; 3University of Cambridge, Cambridge, UK
Introduction: Graves’ disease during pregnancy may cause maternal or neonatal complications, including arrhythmia, thyroid storm, congenital anomalies and neonatal thyroid dysfunction (TD). The optimal timing and frequency of TRAb measurement in pregnant women with a history of TD, and whether fetal monitoring could be limited to those with a strongly positive TRAb, is unclear.
Methods: Retrospective case note review of women with elevated TRAb (>1 iU/l) during pregnancy at our institution (2013–2017).
Results: 47 women had a positive TRAb and/or received ATDs during pregnancy. 4/47 women with a negative TRAb in the first trimester developed a positive TRAb (highest 4.5 iU/l) later in pregnancy. 10/47 had a strongly positive TRAb (>3 iu/l) in the first trimester, of whom the majority (n8) had a positive TRAb (>1 iu/l) later in pregnancy. Only one mild congenital anomaly was recorded in those on ATDs (all PTU, n19). Neonatal TD occurred in five babies; necessitating temporary treatment with carbimazole (n1) or thyroxine (n1).
| TRAb <1 iU/l | TRAb 1-3 iU/l | TRAb >3 iU/l | |
| Number of pregnancies | 4 | 26 | 17 |
| Number of live births | 4 | 26 | 17 |
| Fetal thyroid dysfunction | 0 | 0 | 5 |
| Congenital defects | 1 (No ATD) | 0 | 1 |
Conclusions: Almost all with a strongly positive TRAb in the first trimester have a persistently positive TRAb later in pregnancy. Development of a newly positive TRAb in late pregnancy is rare. No adverse maternal outcome during pregnancy was reported, however neonatal thyroid dysfunction occurred in almost 30% of babies born to women with a strongly positive third trimester TRAb. Our findings suggest that early pregnancy TRAb predicts later TRAb levels; and that screening for fetal thyrotoxicosis should be intensified in women with a strongly positive third trimester TRAb.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more